Researchers Information System

日本語に切り替えるswitch to english

Matsumoto, Kotaro

Institute for Advanced Study Program-Specific Assistant Professor

Matsumoto, Kotaro
list
    Last Updated :2025/11/28

    Basic Information

    Academic Degree

    • 修士(生命科学)(東洋大学)
    • 博士(生命科学)(東洋大学)

    Research History

    • Toyo University, 研究助手

    ID,URL

    researchmap URL

    list
      Last Updated :2025/11/28

      Research

      Research Areas

      • Nanotechnology/Materials, Nanobioscience

      Papers

      • Tumor Targeting and Tumor Growth Inhibition Capability of Mesoporous Silica Nanoparticles in Mouse Models
        Tan Le Hoang Doan; Ngoc Xuan Dat Mai; Kotaro Matsumoto; Fuyuhiko Tamanoi
        Enzymes, 01 Jan. 2018
      • Anticancer Drug Delivery Capability of Biodegradable PMO in the Chicken Egg Tumor Model
        Kotaro Matsumoto; Tan Le Hoang Doan; Ngoc Xuan Dat Mai; Keigo Nakai; Aoi Komatsu; Fuyuhiko Tamanoi
        Enzymes, 01 Jan. 2018
      • Organosilica nanoparticles containing sodium borocaptate (BSH) provide new prospects for boron neutron capture therapy (BNCT): efficient cellular uptake and enhanced BNCT efficacy.
        Mathilde Laird; Kotaro Matsumoto; Yuya Higashi; Aoi Komatsu; Art Raitano; Kendall Morrison; Minoru Suzuki; Fuyuhiko Tamanoi
        Nanoscale advances, 02 May 2023
      • Tumor Accumulation of PIP-Based KRAS Inhibitor KR12 Evaluated by the Use of a Simple, Versatile Chicken Egg Tumor Model
        Yuya Higashi; Shuji Ikeda; Kotaro Matsumoto; Shinsuke Satoh; Aoi Komatsu; Hiroshi Sugiyama; Fuyuhiko Tamanoi
        Cancers, 14 Feb. 2022, Peer-reviewed
      • The CAM Model for CIC-DUX4 Sarcoma and Its Potential Use for Precision Medicine
        Aoi Komatsu; Kotaro Matsumoto; Yuki Yoshimatsu; Yooksil Sin; Arisa Kubota; Tomoki Saito; Ayaka Mizumoto; Shinya Ohashi; Manabu Muto; Rei Noguchi; Tadashi Kondo; Fuyuhiko Tamanoi
        Cells, 01 Oct. 2021, Peer-reviewed
      • Iodine containing porous organosilica nanoparticles trigger tumor spheroids destruction upon monochromatic X-ray irradiation: DNA breaks and K-edge energy X-ray
        Yuya Higashi; Kotaro Matsumoto; Hiroyuki Saitoh; Ayumi Shiro; Yue Ma; Mathilde Laird; Shanmugavel Chinnathambi; Albane Birault; Tan Le Hoang Doan; Ryo Yasuda; Toshiki Tajima; Tetsuya Kawachi; Fuyuhiko Tamanoi
        Scientific Reports, Dec. 2021, Peer-reviewed
      • Construction of boronphenylalanine-loaded biodegradable periodic mesoporous organosilica nanoparticles for BNCT cancer therapy
        Fuyuhiko Tamanoi; Shanmugavel Chinnathambi; Mathilde Laird; Aoi Komatsu; Albane Birault; Takushi Takata; Tan Le Hoang Doan; Ngoc Xuan Dat Mai; Arthur Raitano; Kendall Morrison; Minoru Suzuki; Kotaro Matsumoto
        International Journal of Molecular Sciences, Feb. 2021, Peer-reviewed, Last author
      • Designing mesoporous silica nanoparticles to overcome biological barriers by incorporating targeting and endosomal escape
        Miguel Gisbert-Gazaran; Daniel Lozano; Kotaro Matsumoto; Aoi Komatsu; Miguel Manzano; Fuyuhiko Tamanoi; Maria Vallet-Regi
        ACS Applied Materials & Interfaces, Feb. 2021, Peer-reviewed
      • Studies on the exposure of Gadolinium containing nanoparticles with Monochromatic X-rays drive advances in radiation therapy
        Fuyuhiko Tamanoi; Kotaro Matsumoto; Tan Le Hoang Doan; Ayumi Shiro; Hiroyuki Saito
        Nanomaterials, Jul. 2020, Peer-reviewed
      • Biodegradable periodic mesoporous organosilica (BPMO) loaded with Daunorubicin: A promising nanoparticle-based anticancer drug
        Ngoc Xuan; Dat Mai; Albane Birault; Kotaro Matsumoto; Hanh Kieu Thi Ta; Soontaree Grace Intasa-ard; Kendall Morrison; Phan Bach Thang; Tan Le Hoang Doan; Fuyuhiko Tamanoi
        ChemMedChem, Feb. 2020, Peer-reviewed
      • Destruction of tumor mass by gadolinium-loaded nanoparticles irradiated with monochromatic X-rays: Implications for the Auger therapy
        Kotaro Matsumoto; Hiroyuki Saito; Tan Le-Hoang Doan; Ayumi Shiro; Keigo Nakai; Aoi Komatsu; Masahiko; Tsujimoto; Ryo Yasuda; Tetsuya Kawachi; Toshiki Tajima; Fuyuhiko Tamanoi
        Scientific reports, Sep. 2019, Peer-reviewed, Lead author
      • Patient Derived Chicken Egg Tumor Model (PDcE Model): Current Status and Critical Issues.
        Aoi Komatsu; Kotaro Matsumoto; Tomoki Saito; Manabu Muto; Fuyuhiko Tamanoi
        Cells, 10 May 2019, Peer-reviewed
      • Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer.
        Binh Thanh Vu; Sophia Allaf Shahin; Jonas Croissant; Yevhen Fatieiev; Kotaro Matsumoto; Tan Le-Hoang Doan; Tammy Yik; Shirleen Simargi; Altagracia Conteras; Laura Ratliff; Chiara Mauriello Jimenez; Laurence Raehm; Niveen Khashab; Jean-Olivier Durand; Carlotta Glackin; Fuyuhiko Tamanoi
        Scientific reports, 04 Jun. 2018, Peer-reviewed

      Presentations

      • Establishment of chicken chorioallantoic membrane (CAM) model and application to BNCT experiment using BPA-loaded silica nanoparticles
        Kotaro Matsumoto; Mathilde Laird; Aoi Komatsu; Shanmugavel Chinnathambi; Takushi Takata; Minoru Suzuki; Fuyuhiko Tamanoi
        The 17th Congress on Neutron Capture Therapy, 10 Jul. 2021
      • Evaluation of novel nanoparticle-based anticancer drugs for cancer therapy by using ovarian cancer-transplanted chicken chorioallantoic membrane (CAM).
        Kotaro Matsumoto
        Proceedings of the 6th Japan-Chaina symposium on nanomedicine, 25 May 2018

      Books and Other Publications

      • Various CAM tumor models
        Aoi Komatsu; Yuya Higashi; Kotaro Matsumoto, Joint work
        The Enzymes, Oct. 2019
      • がんの個別化医療を切り拓く鶏卵モデル
        玉野井冬彦; 遠藤良夫; 宇都義浩; 楠橋由貴; 二若真菜; 松本光太郎, Joint work
        実験医学, Jan. 2019
      • Use of mesoporous silica nanoparticles to deliver anticancer agents in animal models.
        Kotaro Matsumoto, Joint work
        Elsevier, 2018, Not refereed
      • Tumor targeting and tumor inhibition capability of biodegradable PMO as examined by using chicken egg tumor model
        Kotaro Matsumoto, Joint work
        Elsevier, 2018, Not refereed

      External funds: Kakenhi

      • がんAuger治療で放射線治療の低酸素問題解決を目指す
        Grant-in-Aid for Scientific Research (C)
        Basic Section 52040:Radiological sciences-related
        Kyoto University
        松本 光太郎
        From 01 Apr. 2024, To 31 Mar. 2027, Granted
        Auger電子;単色X線;ヨウ素含有Hoechst;低酸素状態の腫瘍;がんスフェロイド

      ページ上部へ戻る